EICHORPublic-registry site landscape for NCT03834948, “AO-176 in Multiple Solid Tumor Malignancies”, a Solid Tumor study sponsored by Arch Oncology. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03834948 (registry record) |
| Study title | AO-176 in Multiple Solid Tumor Malignancies |
| Official title | A Phase 1/2 Multicenter, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AO-176 |
| Sponsor | Arch Oncology |
| Condition(s) | Solid Tumor |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 10 |
| Site countries | United States |
Patient-friendly overview of this study: eichor.com/study/NCT03834948.
Eichor generates a preliminary site-risk snapshot for NCT03834948 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Other Solid Tumor trials
← Eichor home · All tracked trials · Solid Tumor studies · Weekly briefs
